SRXN1 and gastric cancer: By integrating the final data, SOD2, sulfiredoxin 1 (SRXN1), neurogenic locus notch homolog protein 1 (NOTCH1), and mitogen-activated protein kinase 14 (MAPK14) were predicted to be the target genes for the anti-gastric cancer effects of WNG [121].